Internet Gold-Golden Lines Ltd. (IGLD) Financials Nov 14,

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Internet Gold-Golden Lines Ltd. (IGLD) Financials Nov 14, 2014, 3:33 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Internet Gold-Golden Lines Ltd.


Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 316.5M 2.34B 3.18B 2.67B 2.65B
Cost of Goods Sold (COGS) incl. D&A 275.79M 2.01B 2.13B 1.76B 1.7B
COGS excluding D&A 250.68M 1.4B 1.3B 1.14B 1.14B
Depreciation & Amortization Expense 25.12M 614.91M 833.94M 613.78M 557.97M
Depreciation 8.44M 285.35M 442.12M - -
Amortization of Intangibles 10.53M 310.53M 364.43M - -
Gross Income 40.71M 328.49M 1.04B 907.83M 947.77M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense - - 643.9M 407.89M 369.03M
Research & Development 0 0 0 0 -
Other SG&A - - 643.9M 407.89M 369.03M
Other Operating Expense 0 (6.7M) (8.1M) 3.89M 43.77M
Unusual Expense 7.95M 12.86M (25.71M) (21.78M) (10.8M)
EBIT after Unusual Expense (7.95M) (12.86M) 25.71M 21.78M 10.8M
Non Operating Income/Expense (747,284) (35.37M) (44.72M) (10.11M) 23.55M
Non-Operating Interest Income 31.65M 47.69M 67.07M 81.16M 110.82M
Equity in Affiliates (Pretax) 0 0 - - 0
Interest Expense 23.49M 109.58M 205.41M 195.78M 226.9M
Gross Interest Expense 23.49M 109.58M 205.41M 195.78M 226.9M
Interest Capitalized 0 0 0 0 0
Pretax Income 40.18M 225.06M 251.24M 393.11M 453.25M
Income Tax 14.71M 103.15M 182.49M 143.91M 145.17M
Income Tax - Current Domestic 8.28M 173.08M 212.96M 186.44M 160.41M
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic 6.43M (69.93M) (30.46M) (42.53M) (15.24M)
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 (62.96M) (60.37M) (63.53M) (69.82M)
Other After Tax Income (Expense) 0 0 0 - 0
Consolidated Net Income 25.46M 58.95M 8.38M 185.66M 238.26M
Minority Interest Expense 9.62M 114.94M 82.72M 195.52M 231.06M
Net Income 15.85M (56M) (74.34M) (9.85M) 7.2M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 15.85M (56M) (74.34M) (9.85M) 7.2M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 15.85M (56M) (74.34M) (9.85M) 7.2M
EPS (Basic) 0.86 (2.94) (3.87) (0.51) 0.37
Basic Shares Outstanding 18.35M 19.04M 19.2M 19.2M 19.2M
EPS (Diluted) 0.86 (3.01) (3.90) (0.53) 0.36
Diluted Shares Outstanding 18.35M 19.04M 19.2M 19.2M 19.2M
EBITDA 65.83M 950.09M 1.24B 1.11B 1.09B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Brinker International Posts Solid Q1 2027 Earnings

Updated Category News Views 80

Strong Earnings Highlight a Winning Streak Brinker International, folks, has done it again. With the latest release of their first quarter fiscal 2027 results, it’s clear they’ve been hitting the right notes, especially at Chili’s. The numbers don't lie—trust me, I've seen my fair share of earnings calls, and this one's got meat on the bones. Let’s break it...

Continue Reading
E-Bike Demo Day Spurs New Jersey's Policy Insights

Updated Category News Views 79

Velotric Sets the Stage for E-Bike Insights The chatter over at Trenton has been electric—and I mean that literally. On October 29, Assemblywoman Tennille R. McCoy will open the gates of the New Jersey State House to host an E-Bike Demonstration and Education Day. The goal? To slap some sense into lawmakers' understanding of the buzzing e-bike market. Velotric, a major...

Continue Reading
Innovative Trial Targets Drug Resistance in Lung Cancer

Updated Category News Views 68

The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...

Continue Reading
ReachWell Revamps Platform for Better Community Reach

Updated Category News Views 79

ReachWell's Fresh Approach: A New Era Begins Become the whisper in the wind reaching ears far and wide—enter the new ReachWell. Sounds lofty? Well, it's shooting for the stars here, folks. This isn’t just some tech upgrade. It’s a whole new brand identity and a refreshed sense of purpose. These guys have tossed everything back on the drawing board, unveiling a...

Continue Reading
H.R. 10549: Hope Charities Pushes for Pharmacy Freedom

Updated Category News Views 63

Hope Charities Takes a Stand for Patients In Prairieville, Hope Charities is throwing its weight behind a bill they believe is brewing up a patient revolution. The Patients Choice in Specialty Pharmacy Act, otherwise known as H.R. 10549, sparked by Representatives Neal Dunn and Joe Wilson, tackles the comfortable partnerships some insurers have been enjoying with their...

Continue Reading
Genefluence Launches Rapid UTI PCR Test at Chelsea Hospital

Updated Category News Views 49

There's a fresh breeze blowing through the dusty corridors of healthcare, shaking things up for the better. You see, Genefluence, the brainchild of Professor Chris Toumazou, isn't just throwing a bunch of tech jargon around—it's setting the stage for a much-needed shake-up in how we handle urinary tract infections (UTIs) and, believe me, it couldn’t have come sooner....

Continue Reading
Labcorp Lifts 2026 Guidance Amid Strong Q3 Performance

Updated Category News Views 119

Labcorp's Q3 Numbers Speak Loud and Clear Another quarter, another robust set of numbers for Labcorp (NYSE:LH). The company is strutting into the spotlight with third-quarter 2026 results that have investors nodding in approval. Revenue surged to $3.81 billion, marking a 6.9% increase from the prior year's $3.56 billion. And get this: adjusted EPS jumped 14.5%, clocking...

Continue Reading
7-Eleven Rolls Out Korean Flavors in Bold Menu Shift

Updated Category News Views 68

7-Eleven's New Global Menu Twist October 2026 sees 7-Eleven, Inc. whip out an intriguing move, venturing east with its new Flavors of Korea menu. They're not just changing the game in convenience store aisles; they're dancing to the beat of global flavors—a shake-up fit for the world's largest convenience retailer. Think about bodega basics getting a spicy Korean...

Continue Reading
AEP's $100B Power Plan: Investing in Tomorrow's Energy

Updated Category News Views 85

Electricity Powerhouse Unleashes Ambitious Plan If you thought American Electric Power (NASDAQ:AEP) was just cruising along, think again. This week, they rolled out an eye-popping $100 billion plan to supercharge their infrastructure and meet soaring electricity demands. It’s like they’re building the future of power right in front of our eyes. Third-quarter earnings...

Continue Reading
Hallmark's Holiday Magic: Cards, Ornaments, Joy

Updated Category News Views 205

Hallmark's Seasonal Bonanza: Cards, Gifts, and More It's that time again when Hallmark rolls out the holiday carpet, the red one you usually just see in front of fancy theaters. Greeting cards, gifts, Keepsake Ornaments, and those nostalgic holiday flicks on Hallmark Channel—it's a full-on festive fiesta. But it's not just about shoving a card in an envelope; it's about...

Continue Reading

Top 5 Most Recently Viewed Articles

Rgenta Therapeutics Presents Innovative Data on RGT-61159

Updated Category News Views 192

Rgenta Therapeutics Unveils Preclinical Data on RGT-61159 WOBURN, Mass. – Rgenta Therapeutics, a pioneering biotechnology firm focused on the development of small molecule drugs targeting RNA for cancer and neurological disorders, has made an exciting announcement regarding its lead program, RGT-61159. This promising small molecule inhibitor, which selectively targets...

Continue Reading
TriMas Packaging Showcases Innovations at Upcoming Trade Events

Updated Category News Views 122

TriMas Packaging's Participation in Major Trade Shows TriMas Packaging, a leading group under TriMas (NASDAQ: TRS), is thrilled to announce its involvement in two prominent trade exhibitions. At these events, the company will display its extensive range of innovative and eco-friendly dispensing and closure product solutions that have garnered attention in the industry....

Continue Reading
Understanding Apollo Global Management's Recent Market Trends

Updated Category News Views 109

Understanding Apollo Global Management's Recent Market Trends The market is currently witnessing a notable shift in investor sentiment towards Apollo Global Management (NYSE: APO). This trend is not only striking but worth examining closely for anyone interested in market movements. Recent tracking of options activity has highlighted an interesting wave of bullish...

Continue Reading
Capricor Faces Securities Fraud Lawsuit: Investor Action Key

Updated Category News Views 16

Investors Take the Stage in Capricor Securities Case Here's something that'll make any shareholder's pulse quicken: Capricor Therapeutics, Inc. (NASDAQ: CAPR) is caught in a whirlwind of legal drama, and it's no soap opera. Rather, it's a class action lawsuit, brought forth by the vigilant folks over at Schall, Brown & Schwartz LLP ('SBS'), aimed squarely at alleged...

Continue Reading
Broad Arrow Auctions Collects $14.5 Million in Sales Triumph

Updated Category News Views 333

Broad Arrow Auctions Kicks Off a Successful Year Broad Arrow Auctions, an esteemed arm of Hagerty, recently embarked on its 2025 auction calendar with a remarkable showcase—the Academy of Art University Collection Auction. Held at the university's museum facilities, this auction captured the attention of classic car enthusiasts and collectors alike. A Glance at the...

Continue Reading